Brokerages Set NeoGenomics, Inc. (NASDAQ:NEO) Price Target at $19.30
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price […]
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price […]
